Zydus receives USFDA’s tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of US$ 77.9 mn in the United States (IQVIA MAT March 24).
There was no observation related to data integrity reported
EDQM has also issued a Certificate of Suitability for Allopurino
Prior to taking charge at the Union Health Ministry, Jadhav planted a sapling at his residence
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Subscribe To Our Newsletter & Stay Updated